The different variant allele frequencies of type I/type II mutations and the distinct molecular landscapes in CALR -mutant essential thrombocythaemia and primary myelofibrosis.

The two different subtypes of mutations may have different impacts on MPN. A lower VAF of type I indicates a greater contribution to disease progression in MPN, and increased nondriver mutations may be important in myelofibrosis progression.